Mealey's (August 15, 2016, 8:18 AM EDT) -- CAMBRIDGE, Mass. — A New York state court judge on July 28 granted summary judgment in a fatal Tysabri brain infection case, finding that the drug’s label warned of the injury the decedent suffered and a failure-to-warn claim is preempted by federal law (Gerald Gentile v. Biogen Idec, Inc., et al., No.1181-CV-03500, Mass. Super., Middlesex Co.; 2016 Mass. Super. LEXIS 238)....